Prodromal symptoms and early intervention to prevent a relapse

ISRCTN ISRCTN17350364
DOI https://doi.org/10.1186/ISRCTN17350364
Secondary identifying numbers N/A
Submission date
27/01/2006
Registration date
27/01/2006
Last edited
18/08/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr J. Arends
Scientific

Department of Psychotic Disorders
Mental Health Care Services Drenthe
P.O. Box 30.007
Assen
9400 RA
Netherlands

Phone +31 (0)592 334883
Email Johan.Arends@GGZDrenthe.nl

Study information

Study designMulticentre randomised single blind active controlled parallel group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Scientific title
Study objectivesCould early treatment of prodromal symptoms prevent or postpone a psychotic relapse in schizophrenia?
Ethics approval(s)Received from local medical ethics committee
Health condition(s) or problem(s) studiedSchizophrenia, Schizophreniform disorder
InterventionThe Symptom Management Module (SMM), one of the independent living skills modules developed by the Los Angeles rehabilitation research group, is a psychosocial intervention to improve the capability of patients with schizophrenia to detect early warning signs (EWS) of a psychosis and to teach the patients to manage them.
Two treatment conditions (symptom management module [N = 46] versus self monitoring [N = 52]) and a comparison group (treatment as usual [N = 49]) in patients with schizophrenia or related psychotic disorders.
Intervention typeOther
Primary outcome measureOccurrence of a psychotic relapse: a worsening of at least two points on the CGI as assessed by psychiatrist and verified by researcher by a PANSS-interview within a week.
Secondary outcome measures1. Hospitalisation
2. Psychopathology
Overall study start date01/01/1997
Completion date01/01/2002

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants147
Key inclusion criteria1. ICD-10 diagnosis of schizophrenia (F20) or schizoaffective disorder (F25)
2. A remitted state established by no more than one score of 4 on the positive scale of the PANSS
3. Necessary skills in Dutch language to undergo a training in Dutch
Key exclusion criteriaSubstance abuse
Date of first enrolment01/01/1997
Date of final enrolment01/01/2002

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Department of Psychotic Disorders
Assen
9400 RA
Netherlands

Sponsor information

Mental Health Care Services Drenthe (Netherlands)
Hospital/treatment centre

Department of Psychotic Disorders
P.O. Box 30.007
Assen
9400 RA
Netherlands

ROR logo "ROR" https://ror.org/0107rkg57

Funders

Funder type

Research organisation

Netherlands Organisation for Health Research and Development (ZonMw)
Private sector organisation / Other non-profit organizations
Alternative name(s)
Netherlands Organisation for Health Research and Development
Location
Netherlands
Support Foundation (Stichting tot Steun) (Netherlands)

No information available

Netherlands Care Cooperative (Zorgcoöperatie Nederland [formerly: De Open Ankh]) (Netherlands)

No information available

The Per V. Petersen Foundation (Netherlands)

No information available

National Foundation of Mental Health Care (Nationaal Fonds Geestelijke Volksgezondheid [NFGV]) (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan